MARATTO

article

Prevalence of multidrug-resistant and Entero-invasive E. coli isolates in ready-to-eat roasted beef sold on the streets of Ibadan metropolis

Abstract

This study investigated the level of contamination of ready-to-eat roasted beef by pathogenic E. coli among street vendors in selected local governments of Ibadan. 100 ready-to-eat meat samples were collected randomly from street vendors within the determined GPS-mapped local government in Ibadan, and questionnaires were given to individual vendors. Enumeration of the total viable aerobic count and coliform count was done, and the result in CFU/g was converted to log/CFU/g. Isolation and culturing were done, presumptive E. coli isolates were confirmed by standard biochemical tests, and all indole-positive presumptive E. coli were subjected to antibiotic susceptibility tests by the disc-diffusion method. A total of 68 E coli strains was isolated from the 100 samples, among which 91.2 % showed resistance to Augmentin, 64.7% to cefuroxime, 63.2% to nitrofurantoin, 33.8% to ceftazidime, 29.4% to cefixime, 16.2% to gentamicin, 11.8% to ciprofloxacin and 10.3% to ofloxacin. E coli isolates with multidrug resistance phenotype were 20.6%. Phylogroup analysis showed that most of the isolates are commensals. Only one E. coli separate from the Enteroinvasive E. coli gene (IpaH) was detected in this study. Therefore, properly monitoring and controlling these vendors is crucial to preventing significant outbreaks of food-borne infections from ready-to-eat beef in the Ibadan metropolis.

Research topics

  • Salmonella and Campylobacter epidemiology
  • Food Safety and Hygiene
  • Escherichia coli research studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1109/seb4sdg60871.2024.10629972

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.